ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
12
views
0
references
Top references
cited by
48
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
982
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Candidal vulvovaginitis.
Author(s):
Robert J Sobel
Publication date:
1993-02-28
Journal:
Clinical obstetrics and gynecology
Keywords:
Administration, Intravaginal
,
Administration, Oral
,
Antifungal Agents
,
administration & dosage
,
therapeutic use
,
Candidiasis, Vulvovaginal
,
diagnosis
,
drug therapy
,
epidemiology
,
Chronic Disease
,
Decision Trees
,
Diagnosis, Differential
,
Female
,
Gynecology
,
methods
,
Humans
,
Prevalence
,
Recurrence
,
Risk Factors
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Methods by AKJournals
Author and article information
Journal
PubMed ID::
8435940
DOI::
10.1097/00003081-199303000-00021
ScienceOpen disciplines:
Chemistry
Keywords:
Administration, Intravaginal
,
Administration, Oral
,
Antifungal Agents
,
administration & dosage
,
therapeutic use
,
Candidiasis, Vulvovaginal
,
diagnosis
,
drug therapy
,
epidemiology
,
Chronic Disease
,
Decision Trees
,
Diagnosis, Differential
,
Female
,
Gynecology
,
methods
,
Humans
,
Prevalence
,
Recurrence
,
Risk Factors
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Administration, Intravaginal
,
Administration, Oral
,
Antifungal Agents
,
administration & dosage
,
therapeutic use
,
Candidiasis, Vulvovaginal
,
diagnosis
,
drug therapy
,
epidemiology
,
Chronic Disease
,
Decision Trees
,
Diagnosis, Differential
,
Female
,
Gynecology
,
methods
,
Humans
,
Prevalence
,
Recurrence
,
Risk Factors
Comments
Comment on this article
Sign in to comment
scite_
Similar content
982
Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.
Authors:
Animesh A. Sinha
,
Ayman A. A. Ewies
Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin.
Authors:
Mark A Turrentine
107. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules versus Fluconazole and Placebo in the Treatment of Acute Vulvovaginal Candidiasis Episodes in Subjects with Recurrent Vulvovaginal Candidiasis (ultraViolet)
Authors:
Mark G. Martens
,
Bassem Maximos
,
Thorsten P Degenhardt
…
See all similar
Cited by
27
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Authors:
Adane Bitew
,
Yeshiwork Abebaw
Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
Authors:
Atsunori Kashiwagi
,
Kenichi Kazuta
,
Satoshi Yoshida
…
Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis
Authors:
Diana Rosentul
,
Corine Delsing
,
Martin Jaeger
…
See all cited by